Plant medicine will become a "new fashion" for drug development

Recently, research experts and scholars from the field of botanical medicine at home and abroad held the "International Symposium on the Sustainable Development and Utilization of Medicinal Plant Resources in Lingnan" held in Chaozhou, and fiercely developed the sustainable development and utilization of botanical medicine resources. discuss. Experts said that the key to sustainable development of botanicals lies in strengthening basic research and establishing scientific and effective quality standards for medicinal plants.

Phytomedicine will become a "new fashion" for drug development, not only in the academic world, but also in the face of the temptation of the nearly 50 billion U.S. dollars in the global market that has already emerged. The industry has also shown a strong desire, and this market is still It is growing faster than the growth rate of the entire pharmaceutical industry. However, sustainability issues of brands and resources are still the shortcomings of the growth of the botanicals industry at this stage. Currently, the growth rate of the botanical drug market averages about 10% to 20%, and 25% of the world's chemical drugs are produced. On plants.

Some experts predict that by 2040 or so, more than half of the world's medicinal plants will be in danger of being threatened or even extinct. Once the plant drugs originally used only in some areas are fully brought to the market, the medicine resources will inevitably be in short supply. Due to complete market adjustment, the behavior of planting medicinal herbs will be lack of planning; secondly, the market barrier will be too low. The phenomenon of shoddy is not uncommon. Third, the lack of professionals, the market processing is not standardized, there is a big worry about the quality of medicinal herbs.

The lack of resources led to the constant rise in the price of raw medicinal herbs, and the quality of medicinal materials in the market was uneven. The pharmaceutical companies stated that in order to improve the plant medicine market, in addition to the internal adjustments and efforts of the plant medicine industry, the government should also promptly introduce the development direction and corresponding supportive policies for the botanical pharmaceutical industry, reasonably formulate the prices of proprietary Chinese medicines, and ensure the reasonable profits of the enterprises. . While the phytomedicine industry continues to grow and expand, companies should develop brand awareness as early as possible by nurturing large brand product groups, possessing their own core technologies and products, enhancing market competitiveness, and increasing market control and share.